Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2009 Mar 31;18(4):1157–1166. doi: 10.1158/1055-9965.EPI-08-1005

Table 1.

Multivariate adjusted* case-control odds ratios and 95% confidence intervals for all breast cancer cases, triple-negative and non triple-negative cases in relation to known and suspected risk factors among women 45 years of age and younger, 1983-1992.

Triple–negative (ER-/PR-/HER2-) status

Controls
(N=1,569)
All breast cancer (N=897) Triple-negative (N=187) Non triple-negative
(N=710)




n (%) n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI) P Value**
Demographic/Lifestyle factors
Age (yrs)
 <30 155 (9.9) 35 (3.9) 1.0 Reference 9 (4.8) 1.0 Reference 26 (3.7) 1.0 Reference
 30-34 297 (18.9) 140 (15.6) 2.1 (1.1-3.9) 38 (20.3) 2.6 (0.8-9.1) 102 (14.4) 2.0 (1.0-3.9)
 35-39 573 (36.5) 335 (37.3) 2.4 (1.3-4.3) 79 (42.2) 2.9 (0.9-9.8) 256 (36.1) 2.2 (1.2-4.2)
 40-45 544 (34.7) 387 (43.1) 2.6 (1.4-4.6) 61 (32.6) 2.2 (0.7-7.4) 326 (45.9) 2.7 (1.4-5.1)
 P for trend .006 .81 .002 .13
Race§§
 White 1482 (94.6) 836 (93.7) 1.0 Reference 178 (95.7) 1.0 Reference 658 (93.2) 1.0 Reference
 Black 27 (1.7) 20 (2.2) 0.9 (0.4-2.5) 3 (1.6) 0.0 N/A 17 (2.4) 1.2 (0.5-3.2)
 Other 58 (3.7) 36 (4.0) 0.9 (0.5-1.7) 5 (2.7) 0.9 (0.3-3.1) 31 (4.4) 0.9 (0.4-1.8) .05
Education
 <College graduate 1035 (66.0) 572 (63.8) 1.0 Reference 119 (63.6) 1.0 Reference 453 (63.8) 1.0 Reference
 College graduate 533 (34.0) 325 (36.2) 1.2 (1.0-1.6) 68 (36.4) 1.3 (0.9-2.0) 257 (36.2) 1.2 (1.0-1.6) .61
Annual income‡‡
 <15,000 184 (11.9) 81 (9.1) 1.0 Reference 14 (7.5) 1.0 Reference 67 (9.5) 1.0 Reference
 15-45/50,000 863 (55.9) 471 (52.9) 1.3 (0.8-1.9) 99 (52.9) 1.2 (0.6-2.6) 372 (52.9) 1.3 (0.8-1.9)
 45/50,000+ 496 (32.1) 338 (38.0) 1.3 (0.8-1.9) 74 (39.6) 1.5 (0.7-3.2) 264 (37.6) 1.2 (0.8-1.9)
 P for trend .39 .24 .64 .55
Family history of breast cancer
 None 807 (67.8) 363 (50.3) 1.0 Reference 78 (47.6) 1.0 Reference 285 (51.1) 1.0 Reference
 1st degree 95 (8.0) 150 (20.8) 3.0 (2.1-4.1) 37 (22.6) 3.5 (2.1-5.9) 113 (20.3) 2.8 (2.0-4.0)
 2nd degree only 289 (24.3) 209 (28.9) 1.7 (1.3-2.2) 49 (29.9) 1.8 (1.2-2.8) 160 (28.7) 1.7 (1.3-2.2) .70
Body mass index (k/m2)
 <18.5 87 (5.6) 35 (4.0) 0.7 (0.4-1.2) 6 (3.2) 0.5 (0.2-1.7) 29 (4.2) 0.8 (0.4-1.4)
 18.5 – 24.9 977 (63.4) 578 (65.6) 1.0 Reference 121 (65.1) 1.0 Reference 457 (65.8) 1.0 Reference
 25.0-29.9 269 (17.4) 151 (17.1) 1.0 (0.7-1.3) 33 (17.7) 1.1 (0.6-1.8) 118 (17.0) 0.9 (0.7-1.3)
 30+ 209 (13.6) 117 (13.3) 0.9 (0.7-1.3) 26 (14.0) 1.3 (0.8-2.2) 91 (13.1) 0.8 (0.6-1.2)
 P for trend .99 .18 .54 .12
Smoking
 Never 801 (51.4) 464 (52.2) 1.0 Reference 100 (54.6) 1.0 Reference 364 (51.6) 1.0 Reference
 Former 332 (21.3) 189 (21.3) 0.9 (0.7-1.2) 34 (18.6) 0.8 (0.5-1.3) 155 (22.0) 0.9 (0.7-1.3)
 Current 424 (27.2) 236 (26.5) 0.9 (0.7-1.2) 49 (26.8) 1.0 (0.6-1.6) 187 (26.5) 0.9 (0.7-1.2) .29
Alcohol use (drinks/wk)
 None/<1 771 (49.2) 442 (49.3) 1.0 Reference 88 (47.1) 1.0 Reference 354 (49.9) 1.0 Reference
 1-3 288 (18.4) 152 (17.0) 1.0 (0.7-1.3) 29 (15.5) 0.8 (0.5-1.4) 123 (17.3) 1.0 (0.7-1.4)
 3+ 507 (32.4) 302 (33.7) 1.1 (0.9-1.4) 70 (37.4) 1.1 (0.7-1.6) 232 (32.7) 1.1 (0.8-1.4)
 P for trend .54 .84 .54 .49
Reproductive factors
Age at menarche
 8-12 737 (47.1) 471 (52.5) 1.0 Reference 98 (52.4) 1.0 Reference 373 (52.5) 1.0 Reference
 13-14 690 (44.1) 351 (39.1) 0.8 (0.6-1.0) 77 (41.2) 0.8 (0.6-1.2) 274 (38.6) 0.7 (0.6-1.0)
 15+ 139 (8.9) 75 (8.4) 0.8 (0.5-1.2) 12 (6.4) 0.4 (0.2-1.0) 63 (8.9) 0.9 (0.6-1.4)
 P for trend .03 .05 .11 .33
Number of live births
 None 396 (25.2) 232 (25.9) 1.0 Reference 53 (28.3) 1.0 Reference 179 (25.2) 1.0 Reference
 1-3 1057 (67.4) 621 (69.2) 0.8 (0.5-1.3) 127 (67.9) 0.9 (0.4-1.9) 494 (69.6) 0.8 (0.5-1.3)
 4+ 116 (7.4) 44 (4.9) 0.5 (0.3-1.0) 7 (3.7) 0.6 (0.2-1.9) 37 (5.2) 0.5 (0.3-1.0)
 P for trend .04 .38 .04 .83
Age at first birth (yrs)
 None 390 (24.9) 230 (25.7) 1.0 Reference 53 (28.3) 1.0 Reference 177 (25.0) 1.0 Reference
 <20 264 (16.8) 116 (12.9) 0.6 (0.3-1.0) 19 (10.2) 0.6 (0.2-1.4) 97 (13.7) 0.6 (0.3-1.0)
 20-29 745 (47.5) 419 (46.8) 0.8 (0.5-1.3) 86 (46.0) 0.9 (0.4-2.0) 333 (47.0) 0.8 (0.5-1.3)
 30+ 170 (10.8) 131 (14.6) 1.0 (0.6-1.8) 29 (15.5) 1.2 (0.5-3.0) 102 (14.4) 1.0 (0.6-1.8)
 P for trend§ .002 .03 .009 .49
Lactation
 Never 313 (26.9) 189 (28.5) 1.0 Reference 33 (24.6) 1.0 Reference 156 (29.4) 1.0 Reference
 <12 494 (42.5) 279 (42.0) 1.1 (0.8-1.4) 63 (47.0) 1.1 (0.7-1.8) 216 (40.8) 1.1 (0.8-1.5)
 12+ 356 (30.6) 196 (29.5) 1.0 (0.7-1.4) 38 (28.4) 1.0 (0.6-1.7) 158 (29.8) 1.0 (0.7-1.4)
 P for trend .97 .99 .98 .78
Abortion
 Never 950 (72.9) 510 (67.3) 1.0 Reference 98 (64.5) 1.0 Reference 412 (68.0) 1.0 Reference
 Ever 354 (27.1) 248 (32.7) 1.4 (1.1-1.8) 54 (35.5) 1.4 (0.9-2.2) 194 (32.0) 1.4 (1.1-1.8) .82
Oral contraceptive use
OC use (yrs)
 Never/<1 407 (25.9) 197 (22.0) 1.0 Reference 22 (11.8) 1.0 Reference 175 (24.7) 1.0 Reference
 1+ 1162 (74.1) 699 (78.0) 1.3 (1.0-1.7) 165 (88.2) 2.5 (1.4-4.3) 534 (75.3) 1.2 (0.9-1.5) .008
OC duration (yrs)††
 1-<3 327 (20.8) 184 (20.5) 1.3 (0.9-1.7) 35 (18.7) 1.6 (0.9-3.3) 149 (21.0) 1.2 (0.9-1.7)
 3-<6 357 (22.8) 220 (24.6) 1.4 (1.0-2.0) 51 (27.3) 2.8 (1.5-5.3) 169 (23.8) 1.2 (0.9-1.7)
 6+ 478 (30.5) 295 (32.9) 1.3 (1.0-1.8) 79 (42.2) 2.9 (1.6-5.3) 216 (30.5) 1.1 (0.8-1.5)
 P for trend .85 .05 .45 .02
Age at first use (yrs)††
 22+ 260 (16.6) 159 (17.7) 1.2 (0.9-1.7) 31 (16.6) 2.0 (1.0-4.1) 128 (18.1) 1.1 (0.8-1.6)
 18-<22 674 (43.0) 390 (43.5) 1.2 (0.9-1.6) 92 (49.2) 2.3 (1.3-4.1) 298 (42.0) 1.1 (0.8-1.4)
 <18 228 (14.5) 150 (16.7) 1.9 (1.3-2.7) 42 (22.5) 3.7 (1.9-7.2) 108 (15.2) 1.6 (1.1-2.3)
 P for trend .05 .13 .10 .84
Years since first use††
 1-<15 313 (19.9) 132 (14.7) 1.3 (0.8-1.9) 36 (19.3) 2.4 (1.1-5.1) 96 (13.5) 1.1 (0.7-1.6)
 15-<20 462 (29.4) 277 (30.9) 1.3 (1.0-1.8) 78 (41.7) 3.0 (1.6-5.4) 199 (28.1) 1.1 (0.8-1.5)
 20+ 387 (24.7) 290 (32.4) 1.4 (1.0-1.9) 51 (27.3) 2.0 (1.1-4.0) 239 (33.7) 1.3 (0.9-1.8)
 P for trend .27 .74 .25 .74
Years since last use††
 Current 120 (7.6) 43 (4.8) 1.0 (0.6-1.8) 16 (8.6) 3.1 (1.2-7.6) 27 (3.8) 0.7 (0.4-1.4)
 1-<5 190 (12.1) 116 (12.9) 1.9 (1.3-2.9) 31 (16.6) 4.2 (2.0-8.6) 85 (12.0) 1.6 (1.1-2.5)
 5-<10 255 (16.3) 136 (15.2) 1.2 (0.8-1.7) 41 (21.9) 3.0 (1.6-5.9) 95 (13.4) 0.9 (0.6-1.3)
 10-<15 339 (21.6) 213 (23.8) 1.3 (1.0-1.8) 55 (29.4) 2.6 (1.4-4.8) 158 (22.3) 1.2 (0.8-1.6)
 15+ 258 (16.4) 191 (21.3) 1.3 (0.9-1.8) 22 (11.8) 1.2 (0.6-2.6) 169 (23.8) 1.3 (0.9-1.8)
 P for trend .86 .04 .39 .01
*

Risk factors adjusted for age, family history of breast cancer, breastfeeding history and OC duration

1 yr prior to reference date

Still and live births

§

P for trend among parous women only

Among parous women

Among gravid women

**

Pheterogeneity (association of risk factor with triple-negative vs. non triple-negative breast cancer)

††

Ptrend and Pheterogeneity among OC users >1 year only

‡‡

Income categories reflect the fact that the two studies combined for the present study used different cut-offs

§§

Due to missing data, race was adjusted for age, breastfeeding history and OC duration, but not family history of breast cancer